Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXO-DEX-SNHL: Intratympanic Dexamethasone-Loaded Exosomes in Acute Sensorineural Hearing Loss
NCT07568184Phase 2Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Apr 2026
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in sensorineural hearing loss (SNHL), sponsored by Kafrelsheikh University. Started Apr 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on NCT07568184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568184.